Biofrontera Inc. provided earnings guidance for the fiscal year of 2022. For the period, the company expects total revenues to increase by at least 30% compared with 2021, including typical seasonal strength in the first and fourth quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -0.01% | -5.84% | -62.10% |
May. 16 | Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.10% | 5.34M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.11% | 238B | |
+7.02% | 204B | |
-5.69% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. Provides Earnings Guidance for the Fiscal Year of 2022